Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Skin Neoplasms 1Sarcoma, Kaposi 1HIV Infections 1

Interventions

Zidovudine 3Methotrexate 2Leucovorin 2Dexamethasone 2fludarabine phosphate 1X-Rays 1Whole-Body Irradiation 1Vincristine 1Triage 1Transurethral Resection of Prostate 1Therapeutics 1Tetanus Toxoid 1Standard of Care 1Smoking Devices 1Semaxinib 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Peripheral Blood Stem Cell Transplantation 1Papillomavirus Vaccines 1Papanicolaou Test 1Mycophenolic Acid 1Measles-Mumps-Rubella Vaccine 1Massage 1Mass Screening 1Inosine Pranobex 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Heptavalent Pneumococcal Conjugate Vaccine 1Hepatitis B Vaccines 1Health Promotion 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × HIV Infections × Semaxinib × Clear all
NCT00002226 2005-06-24

Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase NA Completed
30 enrolled
DermatologicSarcoma

Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡